Lilli Petruzzelli

Lilli Petruzzelli is an accomplished pharmaceutical executive with extensive experience in early clinical development and oncology. Currently serving as Senior Vice President of Early Clinical Development at Genentech since March 2021, Lilli has previously held significant roles, including Group Vice President at Incyte from November 2019 to February 2021 and Vice President of Translational Clinical Oncology at Novartis from October 2014 to October 2019. Prior to that, Lilli was the Site Head of Oncology Translational Medicine at Novartis from July 2011 to 2014, showcasing a strong background in oncology and translational medicine.